2015
DOI: 10.3389/fimmu.2015.00322
|View full text |Cite
|
Sign up to set email alerts
|

Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases

Abstract: Antigen presentation is in the center of the immune system, both in host defense against pathogens, but also when the system is unbalanced and autoimmune diseases like multiple sclerosis (MS) develop. It is not just by chance that a major histocompatibility complex gene is the major genetic susceptibility locus in MS; a feature that MS shares with other autoimmune diseases. The exact etiology of the disease, however, has not been fully understood yet. T cells are regarded as the major players in the disease, b… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
80
0
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 95 publications
(82 citation statements)
references
References 350 publications
(371 reference statements)
0
80
0
2
Order By: Relevance
“…One of the important issues in MS and other inflammatory diseases of the CNS is understanding the requisites of autoantigenic peptides to induce CNS inflammation (Riedhammer and Weissert, 2015). Beside presentation of autoantigen-derived peptides on MHC molecules and the availability of reactive T-cell and B-cell repertoires as well as the presence of the target antigen in the CNS, pathways of cellular activation exist that allow disease development.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…One of the important issues in MS and other inflammatory diseases of the CNS is understanding the requisites of autoantigenic peptides to induce CNS inflammation (Riedhammer and Weissert, 2015). Beside presentation of autoantigen-derived peptides on MHC molecules and the availability of reactive T-cell and B-cell repertoires as well as the presence of the target antigen in the CNS, pathways of cellular activation exist that allow disease development.…”
Section: Resultsmentioning
confidence: 99%
“…Encephalitogenic peptides presented on MHC class II molecules to T cells lead to a program that forces lymphocytes to be activated and migrate towards the CNS (Riedhammer and Weissert, 2015). Adjuvant contributes by affecting multiple signaling pathways in lymphocytes as well as in organ-resident cells like in the CNS.…”
Section: Introductionmentioning
confidence: 99%
“…In these disorders, immunologic tolerance to self-antigens is broken (1). This failure can be on the T cell as well as on the B cell side or on both sides.…”
Section: Introductionmentioning
confidence: 99%
“…In many autoimmune and paraneoplastic diseases of the CNS, the B cell response is much better characterized as compared with the T cell response (1, 9). T cell help is required for differentiation of B cells into plasma cells and affinity maturation of antibodies (10, 11).…”
Section: Introductionmentioning
confidence: 99%
“…6,7 APCs of the myeloid lineage (m-APC), comprising DCs and macrophages (MΦ), and of the lymphoid lineage (B cells) are discerned. M-APCs, DCs in particular, have a key regulatory role in T cell tolerance and immunity against self-antigens.…”
Section: Regulation Of T Cell Autoimmunity By Myeloid Antigen Presentmentioning
confidence: 99%